Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estriol Before Vaginal Surgery for Prolapse
NCT02906111Phase 4Unknown
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of estriol in vaginal atrophy and pelvic organ prolapse (POP) (2 arms). Primary endpoints: Vaginal Health Index at 12 weeks, Vaginal Maturation Index at 12 weeks and 3 more. Status: unknown.
02
Drugs
estriol
03
Conditions
vaginal atrophypelvic organ prolapse (POP)
Beyond the preview
Go deeper on NCT02906111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906111.